Patent · US Active

Compositions and methods for treating Huntington's disease

US11951121B2 · kind B2 · utility

0Cited by

223References

29Claims

0Family size

Assignee

VOYAGER THERAPEUTICS, INC. · US

Inventors

Dinah Wen-Yee Sah · Boston, US
Jinzhao Hou · Cambridge, US
Pengcheng Zhou · Lexington, US
Xin Wang · Beijing, CN
Jochen Deckert · Bayreuth, DE
Markus Hossbach · Kulmbach, DE

Key dates

Filing date	May 18, 2017
Grant date	Apr 9, 2024
Priority date	—
Expiry date	Dec 16, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2750/14143
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to small interfering RNA (siRNA) molecules against the HTT gene, adeno-associated viral (AAV) vectors encoding siRNA molecules and methods for treating Huntington's Disease (HD) using the siRNA molecules and AAV vectors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.